Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kishi, H"" wg kryterium: Wszystkie pola


Tytuł:
Assisted reproductive technology in Japan: A summary report for 2021 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology.
Autorzy:
Katagiri Y; Department of Obstetrics and Gynecology, Faculty of Medicine Toho University Tokyo Japan.
Jwa SC; Department of Obstetrics and Gynecology Jichi Medical University Tochigi Japan.
Kuwahara A; Department of Obstetrics and Gynecology, Graduate School of Biomedical Sciences Tokushima University Tokushima Japan.
Iwasa T; Department of Obstetrics and Gynecology, Graduate School of Biomedical Sciences Tokushima University Tokushima Japan.
On M; Department of Obstetrics and Gynecology Tokyo Medical University Tokyo Japan.
Kato K; Kato Ladies Clinic Tokyo Japan.
Kishi H; Department of Obstetrics and Gynecology The Jikei University School of Medicine Tokyo Japan.
Kuwabara Y; Department of Obstetrics and Gynecology Nippon Medical School Tokyo Japan.
Taniguchi F; Department of Obstetrics and Gynecology Tottori University Faculty of Medicine Tottori Japan.
Harada M; Department of Obstetrics and Gynecology, Graduate School of Medicine The University of Tokyo Tokyo Japan.
Iwase A; Department of Obstetrics and Gynecology Gunma University Graduate School of Medicine Maebashi Japan.
Osuga Y; Department of Obstetrics and Gynecology, Graduate School of Medicine The University of Tokyo Tokyo Japan.
Pokaż więcej
Źródło:
Reproductive medicine and biology [Reprod Med Biol] 2023 Dec 30; Vol. 23 (1), pp. e12552. Date of Electronic Publication: 2023 Dec 30 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Fyn-Mediated Paxillin Tyrosine 31 Phosphorylation Regulates Migration and Invasion of Breast Cancer Cells.
Autorzy:
Zhang Y; Department of Molecular and Cellular Physiology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
Zheng H; Department of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
Xu M; Department of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
Maeda N; Department of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
Tsunedomi R; Department of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
Kishi H; Department of Molecular and Cellular Physiology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
Nagano H; Department of Gastroenterological, Breast and Endocrine Surgery, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
Kobayashi S; Department of Molecular and Cellular Physiology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 05; Vol. 24 (21). Date of Electronic Publication: 2023 Nov 05.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/metabolism
Female ; Humans ; Cell Movement ; Paxillin/metabolism ; Phosphorylation ; Tyrosine/metabolism
Czasopismo naukowe
Tytuł:
Novel therapeutic strategies for injured endometrium: intrauterine transplantation of menstrual blood‑derived cells from infertile patients.
Autorzy:
Hosoya S; Center for Regenerative Medicine, National Center for Child Health and Development Research Institute, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato, Tokyo, 105-8461, Japan.; Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
Yokomizo R; Center for Regenerative Medicine, National Center for Child Health and Development Research Institute, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato, Tokyo, 105-8461, Japan.; Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
Kishigami H; Center for Regenerative Medicine, National Center for Child Health and Development Research Institute, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
Fujiki Y; Center for Regenerative Medicine, National Center for Child Health and Development Research Institute, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
Kaneko E; Division of Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
Amita M; Division of Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
Saito T; Division of Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
Kishi H; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato, Tokyo, 105-8461, Japan.
Sago H; Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan.
Okamoto A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato, Tokyo, 105-8461, Japan.
Umezawa A; Center for Regenerative Medicine, National Center for Child Health and Development Research Institute, 2-10-1 Okura, Setagaya, Tokyo, 157-8535, Japan. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2023 Oct 15; Vol. 14 (1), pp. 297. Date of Electronic Publication: 2023 Oct 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Endometrium*
Infertility*/prevention & control
Female ; Animals ; Humans ; Uterus ; Fertility ; Menstruation
Czasopismo naukowe
Tytuł:
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.
Autorzy:
Kobayashi E; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Kamihara Y; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Arai M; Department of Pediatrics, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Wada A; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Kikuchi S; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Hatano R; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Iwao N; Department of Hematology, Juntendo University Shizuoka Hospital, Izunokuni City, Shizuoka 410-2211, Japan.
Susukida T; Division of Host Defences, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Ozawa T; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Adachi Y; Department of Pediatrics, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Kishi H; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Dang NH; Division of Hematology/Oncology, University of Florida, Gainesville, FL 32610-0275, USA.
Yamada T; Department of Pathology, Saitama Medical University, 38 Morohongo, Moroyama, Saitama 3500495, Japan.
Hayakawa Y; Division of Host Defences, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Morimoto C; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Sato T; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Aug 14; Vol. 12 (16). Date of Electronic Publication: 2023 Aug 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Chimeric Antigen*
Lymphoma, T-Cell*
Animals ; Mice ; T-Lymphocytes ; CD28 Antigens ; Dipeptidyl Peptidase 4 ; Antibodies, Monoclonal ; Cell- and Tissue-Based Therapy
Czasopismo naukowe
Tytuł:
Vascular endothelial growth factor isoforms are expressed in the uterus during estrous cycle of golden hamsters (Mesocricetus auratus).
Autorzy:
Kishi H; Department of Public Health, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Komatsu W; Department of Public Health, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Uchiyama K; Department of Public Health, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Takayama H; Department of Public Health, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Udagawa T; Department of Public Health, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Ohhira S; Department of Public Health, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Kobashi G; Department of Public Health, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Pokaż więcej
Źródło:
Animal science journal = Nihon chikusan Gakkaiho [Anim Sci J] 2023 Jan-Dec; Vol. 94 (1), pp. e13804.
Typ publikacji:
Journal Article
MeSH Terms:
Vascular Endothelial Growth Factor A*/genetics
Vascular Endothelial Growth Factor A*/metabolism
Uterus*/metabolism
Cricetinae ; Female ; Humans ; Animals ; Mice ; Mesocricetus ; Vascular Endothelial Growth Factors/metabolism ; Endometrium/metabolism ; Estrous Cycle ; Protein Isoforms/genetics ; Protein Isoforms/metabolism
Czasopismo naukowe
Tytuł:
GATS tag system is compatible with biotin labelling methods for protein analysis.
Autorzy:
Yamada K; Division of Cell-Free Life Science, Proteo-Science Center, Ehime University, 3 Bunkyo-Cho, Matsuyama, Ehime, 790-8577, Japan.
Soga F; Division of Cell-Free Life Science, Proteo-Science Center, Ehime University, 3 Bunkyo-Cho, Matsuyama, Ehime, 790-8577, Japan.
Tokunaga S; Division of Cell-Free Life Science, Proteo-Science Center, Ehime University, 3 Bunkyo-Cho, Matsuyama, Ehime, 790-8577, Japan.
Nagaoka H; Division of Malaria Research, Proteo-Science Center, 3 Bunkyo-Cho, Matsuyama, Ehime, 790-8577, Japan.
Ozawa T; Department of Immunology, Faculty of Medicine, Academic Assembly, Advanced Antibody Drug Development Center, University of Toyama, Toyama, 930-0194, Japan.
Kishi H; Department of Immunology, Faculty of Medicine, Academic Assembly, Advanced Antibody Drug Development Center, University of Toyama, Toyama, 930-0194, Japan.
Takashima E; Division of Malaria Research, Proteo-Science Center, 3 Bunkyo-Cho, Matsuyama, Ehime, 790-8577, Japan.
Sawasaki T; Division of Cell-Free Life Science, Proteo-Science Center, Ehime University, 3 Bunkyo-Cho, Matsuyama, Ehime, 790-8577, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 23; Vol. 13 (1), pp. 10243. Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biotin*/chemistry
Lysine*/metabolism
Animals ; Humans ; Biotinylation ; Peptides/chemistry ; Epitopes ; Antibodies, Monoclonal ; Mammals/metabolism
Czasopismo naukowe
Tytuł:
DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.
Autorzy:
Kikuchi S; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Wada A; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Kamihara Y; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Okazaki K; Center for Clinical Research, Toyama University Hospital, 2630 Sugitani, Toyama 930-0194, Japan.
Jawaid P; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Rehman MU; Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi 74800, Pakistan.
Kobayashi E; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Susukida T; Section of Host Defences, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Minemura T; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Nabe Y; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Iwao N; Department of Hematology, Juntendo University Shizuoka Hospital, 1129 Nagaoka, Izunokuni City, Shizuoka 410-2295, Japan.
Ozawa T; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Hatano R; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo Bunkyo-ku, Tokyo 113-8421, Japan.
Yamada M; JEM Utilization Center Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency (JAXA), 2-1-1 Sengen, Tsukuba-shi 305-8505, Japan.
Kishi H; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Matsuya Y; Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Mizuguchi M; Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Hayakawa Y; Section of Host Defences, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Dang NH; Division of Hematology/Oncology, University of Florida, Gainesville, FL 32610, USA.
Sakamoto Y; School of Pharmacy, Iwate Medical University, 1-1-1 Idaidori, Yahaba 028-3694, Japan.
Morimoto C; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo Bunkyo-ku, Tokyo 113-8421, Japan.
Sato T; Department of Hematology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Apr 06; Vol. 12 (7). Date of Electronic Publication: 2023 Apr 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematologic Neoplasms*/drug therapy
Hematologic Neoplasms*/metabolism
Cell Line, Tumor ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Humans ; Protease Inhibitors/pharmacology ; Protease Inhibitors/therapeutic use ; Pyroptosis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies